Phase 4 Alzheimer's Disease Trial, Not Yet Recruiting NCT06662526 Sponsor: University of Chile Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 4 Alzheimer's Disease Trial, Not Yet Recruiting

NCT06662526
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between the ages of 55 and 70.
  • People who have been diagnosed with major depressive disorder or bipolar disorder (type I or type II), either currently or at some point in the past, according to standard psychiatric diagnostic guidelines (DSM-5).
  • People who have read and signed an informed consent form before the study begins.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People currently being treated for a mood disorder with lithium.
  • People who have had alcohol dependency in the past month.
  • People who currently have, or have a history of, serious unstable medical conditions that would make taking lithium unsafe (confirm with trial site).
  • People who currently have or have had severe kidney disease, or whose baseline kidney function measurement (creatinine) is above 1.5 mg/dl.
  • People who are currently experiencing serious thoughts of suicide with a specific plan and intention to act on it, as measured by a standard assessment tool (C-SSRS score above 3).
  • People who currently have or have had severe thyroid disease, or whose baseline thyroid hormone level (TSH) is above 5.0 uUI/dl.
  • People who currently have a diagnosis of any form of dementia.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 August 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: +56 966011954

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
University of Chile
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 November 2029

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Incidence of MCI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov